Heterogeneity of obsessive-compulsive disorder: A literature review

Harvard Review of Psychiatry

Volumn 11, Issue 3, 2003, Pages 113-132

  Lochner, Christine ^a   Stein, Dan J ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b NONE

Author keywords

Compulsive; Dopamine; Impulsive; Obsessive compulsive disorder; OCD spectrum disorders; Serotonin; Subtypes

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; ANTICONVULSIVE AGENT; CLOMIPRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

ADULT; BEHAVIOR THERAPY; CHILD; CLINICAL TRIAL; COMORBIDITY; DISEASE CLASSIFICATION; DRUG RESPONSE; FAMILY STUDY; FEMALE; HUMAN; LITERATURE; MALE; MEDLINE; NERVOUSNESS; NEUROIMMUNOLOGY; NEUROPSYCHIATRY; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PHENOMENOLOGY; PRIORITY JOURNAL; PSYCHOBIOLOGY; REVIEW; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SIDE EFFECT; SYMPTOMATOLOGY; TIC;

DOPAMINE; HUMANS; MEDLINE; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0038462034     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.1080/10673220303949     Document Type: Review

References (245)

1. Stoll AL, Tohen M, Baldessarini RJ. Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry 1992;149:638-40.
2. Hollander E. Introduction. In: Hollander, E. Obsessive-compulsive related disorders. Washington, DC: American Psychiatric Press, 1993:1-16.
3. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45:1094-9.
4. Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry 1994;55(suppl):5-10.
5. Rasmussen SA, Tsuang MT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 1986;143:317-22.
6. Rettew DC, Swedo SE, Leonard HL, Lenane MC, Rapoport JL. Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1992;31:1050-6.
7. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000;23:563-86.
8. Rauch SL, Savage CR, Alpert NM, Fischman AJ, Jenike MA. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry 1997;42:446-52.
9. Zohar J, Insel TR. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry 1987;22:667-87.
10. Zohar J, Insel TR. Drug treatment of obsessive-compulsive disorder. J Affect Disord 1987;13:193-202.
11. Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry 1990;51(suppl):36-43.
12. Klein DF. Pharmacotherapy of obsessive-compulsive disorder. Encephale 1990;16:331-4.
13. Jenike MA. Pharmacologic treatment of obsessive-compulsive disorders. Psychiatr Clin North Am 1992;15:895-919.
14. Greist JH, Jefferson JW. Pharmacotherapy for obsessive-compulsive disorder. Br J Psychiatry 1998(suppl);64-70.
15. Minichiello WE, Baer L, Jenike MA. Behavior therapy for the treatment of obsessive-compulsive disorder: theory and practice. Compr Psychiatry 1988;29:123-37.
16. Greist JH. New developments in behaviour therapy for obsessive-compulsive disorder. Int Clin Psychopharmacol 1996;11(suppl 5):63-73.
17. Esman AH. Psychoanalysis and general psychiatry: obsessive-compulsive disorder as paradigm. J Am Psychoanal Assoc 1989;37:319-36.
18. Rapoport JL, Wise SP. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. Psychopharmacol Bull 1988;24:380-4.
19. Insel TR. Toward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:739-44.
20. Leckman JF, Zhang H, Alsobrook JP, Pauls DL. Symptom dimensions in obsessive-compulsive disorder: toward quantitative phenotypes. Am J Med Genet 2001;105:28-30.
21. Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1999;56:121-7.
22. Nestadt G, Samuels JF, Riddle MA, Bienvenu OJ, Liang KY, Grados MA, et al. Obsessive-compulsive disorder: defining the phenotype. J Clin Psychiatry 2002;63(suppl 6):5-7.
23. Baer L. Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 1994;55(suppl): 18-23.
24. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997;154:911-7.
25. Summerfeldt LJ, Richter MA, Antony MM, Swinson RP. Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav Res Ther 1999;37:297-311.
26. Hodgson RJ, Rachman S. Obsessional-compulsive complaints. Behav Res Ther 1977;15:389-95.
27. Van Oppen P, Hoekstra RJ, Emmelkamp PM. The structure of obsessive-compulsive symptoms. Behav Res Ther 1995;33:15-23.
28. Calamari JE, Wiegartz PS, Janeck AS. Obsessive-compulsive disorder subgroups: a symptom-based clustering approach. Behav Res Ther 1999;37:113-25.
29. Sanavio E. Obsessions and compulsions: the Padua Inventory. Behav Res Ther 1988;26:169-77.
30. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-11.
31. Pitman RK. Pierre Janet on obsessive-compulsive disorder (1903). Review and commentary. Arch Gen Psychiatry 1987;44:226-32.
32. Rasmussen SA, Eisen J. Phenomenology of OCD: clinical subtypes, heterogeneity and coexistence. In: Zohar Y, Insel TR, Rasmussen SA, eds. Psychobiology of OCD. New York: Springer-Verlag, 1991:13-43.
33. Ball SG, Baer L, Otto MW. Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: a quantitative review. Behav Res Ther 1996;34:47-51.
34. Khanna S, Mukherjee D. Checkers and washers: valid subtypes of obsessive-compulsive disorder. Psychopathology 1992;25:283-8.
35. Perugi G, Akiskal HS, Pfanner C, Presta S, Gemignani A, Milanfranchi A, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord 1997;46:15-23.
36. Frost RO, Steketee G, Williams LF, Warren R. Mood, personality disorder symptoms and disability in obsessive compulsive boarders: a comparison with clinical and nonclinical controls. Behav Res Ther 2000;38:1071-81.
37. Rasmussen SA, Eisen JL. Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. Psychopharmacol Bull 1988;24:466-70.
38. Takeuchi A, Nakagawa A, Harai H, Nakatani E, Fujikawa S, Yoshizato C, et al. Primary obsessional slowness: long-term findings. Behav Res Ther 1997;35:445-9.
39. Rachman S. Primary obsessional slowness. Behav Res Ther 1974;12:9-18.
40. Veale D. Classification and treatment of obsessional slowness. Br J Psychiatry 1993; 162:198-203.
41. Galderisi S, Mucci A, Catapano F, D'Amato AC, Maj M. Neuropsychological slowness in obsessive-compulsive patients. Is it confined to tests involving the fronto-subcortical systems? Br J Psychiatry 1995;167:394-8.
42. Attiullah N, Eisen JL, Rasmussen SA. Clinical features of obsessive-compulsive disorder. Psychiatr Clin North Am 2000;23:469-91.
43. Insel TR, Akiskal HS. Obsessive-compulsive disorder with psychotic features: a phenomenglogic analysis. Am J Psychiatry 1986;143:1527-33.
44. Lelliott PT, Noshirvani HF, Basoglu M, Marks IM, Monteiro WO. Obsessive-compulsive beliefs and treatment outcome. Psychol Med 1988;18:697-702.
45. Foa EB, Kozak MJ, Goodman WK, Hollander E, Jenike MA, Rasmussen SA. DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry 1995;152:90-6.
46. Eisen JL, Rasmussen SA, Phillips KA, Price LH, Davidson J, Lydiard RB, et al. Insight and treatment outcome in obsessive-compulsive disorder. Compr Psychiatry 2001;42:494-7.
47. Matsunaga H, Kiriike N, Matsui T, Oya K, Iwasaki Y, Koshimune K, et al. Obsessive-compulsive disorder with poor insight. Compr Psychiatry 2002;43:150-7.
48. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
49. Kozak MJ, Foa EB. Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behav Res Ther 1994;32:343-53.
50. Damecour CL, Charron M. Hoarding: a symptom, not a syndrome. J Clin Psychiatry 1998;59:267-72.
51. Catapano F, Sperandeo R, Perris F, Lanzaro M, Maj M. Insight and resistance in patients with obsessive-compulsive disorder. Psychopathology 2001;34:62-8.
52. Okasha A, Saad A, Khalil AH, el Dawla AS, Yehia N. Phenomenology of obsessive-compulsive disorder: a transcultural study. Compr Psychiatry 1994;35:191-7.
53. Abramowitz JS, Brigidi BD, Foa EB. Health concerns in patients with obsessive-compulsive disorder. J Anxiety Disord 1999;13:529-39.
54. Geller D, Biederman J, Jones J, Park K, Schwartz S, Shapiro S, et al. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry 1998;37:420-7.
55. Pigott TA, L'Heureux F, Dubbert B, Bernstein S, Murphy DL. Obsessive compulsive disorder: comorbid conditions. J Clin Psychiatry 1994;55(suppl):15-27.
56. Bogetto F, Venturello S, Albert U, Maina G, Ravizza L. Gender-related clinical differences in obsessive-compulsive disorder. Eur Psychiatry 1999; 14:434-41.
57. Castle DJ, Deale A, Marks IM. Gender differences in obsessive compulsive disorder. Aust N Z J Psychiatry 1995;29:114-7.
58. Lensi P, Cassano GB, Correddu G, Ravagli S, Kunovac JL, Akiskal HS. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiatry 1996; 169:101-7.
59. Marks IM. Fears, phobias and rituals. New York: Oxford University Press, 1987.
60. Minichiello WE, Baer L, Jenike MA, Holland A. Age of onset of major subtypes of obsessive-compulsive disorder. J Anxiety Disord 1990;4:147-50.
61. Rachman S, Hodgson R. Obsessions and compulsions. Englewood Cliffs, NJ: Prentice-Hall, 1980.
62. Stern R, Cobb J. Phenomenology of obsessive-compulsive neurosis. Br J Psychiatry 1978;132:233-9.
63. Swedo SE, Rapoport JL. Phenomenology and differential diagnosis of obsessive-compulsive disorder in children and adolescents. In: Rapoport JL, ed. Obsessive-compulsive disorder in children and adolescents. Washington, DC: American Psychiatric Press, 1989:13-32.
64. Skoog G. Onset of anancastic conditions: a clinical study. Acta Psychiatr Scand 1965;suppl 184:1-82.
65. Fischer DJ, Himle JA, Hanna GL. Age and gender effects on obsessive-compulsive symptoms in children and adults. Depress Anxiety 1997;4:237-9.
66. Zohar AH. The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 1999;8:445-60.
67. Noshirvani HF, Kasvikis Y, Marks IM, Tsakiris F, Monteiro WO. Gender-divergent aetiological factors in obsessive-compulsive disorder. Br J Psychiatry 1991;158:260-3.
68. Thomsen PH. Obsessive-compulsive disorder in children and adolescents: predictors in childhood for long-term phenomenological course. Acta Psychiatr Scand 1995;92:255-9.
69. Ravizza L, Maina G, Bogetto F. Episodic and chronic obsessive-compulsive disorder. Depress Anxiety 1997;6:154-8.
70. Kasvikis JG, Tsakiris F, Marks I, Basoglu M, Noshirvani HF. Women with obsessive-compulsive disorder frequently report a past history of anorexia nervosa. Int J Eat Disord 1986;5:1069-75.
71. Lennkh C, Strnad A, Bailer U, Biener D, Fodor G, de Zwaan M. Comorbidity of obsessive compulsive disorder in patients with eating disorders. Eat Weight Disord 1998;3:37-41.
72. Welner A, Reich T, Robins E, Fishman R, Van Doren T. Obsessive-compulsive neurosis: record, follow-up, and family studies. I. Inpatient record study. Compr Psychiatry 1976;17:527-39.
73. Matsunaga H, Kiriike N, Matsui T, Miyata A, Iwasaki Y, Fujimoto K, et al. Gender differences in social and interpersonal features and personality disorders among Japanese patients with obsessive-compulsive disorder. Compr Psychiatry 2000;41:266-72.
74. Nestadt G, Lan T, Samuels J, Riddle M, Bienvenu OJ III, Liang KY, et al. Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex. Am J Hum Genet 2000;67:1611-6.
75. Cavallini MC, Pasquale L, Bellodi L, Smeraldi E. Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet 1999;88:38-43.
76. Camarena B, Rinetti G, Cruz C, Gomez A, de La Fuente JR, Nicolini H. Additional evidence that genetic variation of MAOA gene supports a gender subtype in obsessive-compulsive disorder. Am J Med Genet 2001;105:279-82.
77. Stein DJ, Hollander E, Simeon D, Cohen L, Islam MN, Aronowitz B. Neurological soft signs in female trichotillomania patients, obsessive-compulsive disorder patients, and healthy control subjects. J Neuropsychiatry Clin Neurosci 1994;6:18-47.
78. Williams KE, Koran LM. Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. J Clin Psychiatry 1997;58:330-4.
79. Diaz SF, Grush LR, Sichel DA, Cohen LS. Obsessive-compulsive disorder in pregnancy and the puerperium. In: Pato MT, Steketee G, eds. OCD across the life cycle. Washington, DC: American Psychiatric Press, 1997:97-112.
80. Neziroglu F, Anemone R, Yaryura-Tobias JA. Onset of obsessive-compulsive disorder in pregnancy. Am J Psychiatry 1992;149:947-50.
81. Altshuler LL, Hendrick V, Cohen LS. Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry 1998;59(suppl 2):29-33.
82. Maina G, Albert U, Bogetto F, Vaschetto P, Ravizza L. Recent life events and obsessive-compulsive disorder (OCD): the role of pregnancy/delivery. Psychiatry Res 1999;89:49-58.
83. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 1997;94: 4572-5.
84. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, et al. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 1999;45:1178-89.
85. Camarena B, Cruz C, de la Fuente JR, Nicolini H. A higher frequency of a low activity-related allele of the MAO-A gene in females with obsessive-compulsive disorder. Psychiatr Genet 1998; 8:255-7.
86. Swedo SE, Rapoport JL, Leonard H, Lenane M, Cheslow D. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry 1989;46:335-41.
87. Rapoport JL, Swedo SE, Leonard HL. Childhood obsessive compulsive disorder. J Clin Psychiatry 1992;53(suppl):11-6.
88. Wever C, Rey JM. Juvenile obsessive-compulsive disorder. Aust N Z J Psychiatry 1997;31:105-13.
89. Toro J, Cervera M, Osejo E, Salamero M. Obsessive-compulsive disorder in childhood and adolescence: a clinical study. J Child Psychol Psychiatry 1992;33:1025-37.
90. Flament MF, Whitaker A, Rapoport JL, Davies M, Berg CZ, Kalikow K, et al. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry 1988;27:764-71.
91. Eichstedt JA, Arnold SL, Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev 2001;21:137-57.
92. do Rosario-Campos MC, Leckman JF, Mercadante MT, Shavitt RG, Prado Hd HS, Sada P, et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry 2001;158:1899-903.
93. Honjo S, Hirano C, Murase S, Kaneko T, Sugiyama T, Ohtaka K, et al. Obsessive-compulsive symptoms in childhood and adolescence. Acta Psychiatr Scand 1989;80:83-91.
94. Swedo SE, Leonard HL, Rapoport JL. Childhood-onset obsessive compulsive disorder. Psychiatr Clin North Am 1992;15:767-75.
95. Kohn R, Westlake RJ, Rasmussen SA, Marsland RT, Norman WH. Clinical features of obsessive-compulsive disorder in elderly patients. Am J Geriatr Psychiatry 1997;5:211-5.
96. Weiss AP, Jenike MA. Late-onset obsessive-compulsive disorder: a case series. J Neuropsychiatry Clin Neurosci 2000;12:265-8.
97. Lenane MC, Swedo SE, Leonard H, Pauls DL, Sceery W, Rapoport JL. Psychiatric disorders in first degree relatives of children and adolescents with obsessive compulsive disorder. J Am Acad Child Adolesc Psychiatry 1990;29:407-12.
98. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995;152:76-84.
99. Eisen JL, Goodman WK, Keller MB, Warshaw MG, DeMarco LM, Luce DD, et al. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry 1999;60:346-51.
100. Grabe HJ, Meyer C, Hapke U, Rumpf HJ, Freyberger HJ, Dilling H, et al. Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in Northern Germany. Eur Arch Psychiatry Clin Neurosci 2001;251:130-5.
101. du Toit PL, van Kradenburg J, Niehaus D, Stein DJ. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry 2001;42:291-300.
102. Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BA, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000;48:287-93.
103. Eisen JL, Rasmussen SA. Obsessive compulsive disorder with psychotic features. J Clin Psychiatry 1993;54:373-9.
104. Geller DA, Biederman J, Faraone S, Agranat A, Cradock K, Hagermoser L, et al. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents and adults. J Nerv Ment Dis 2001;189:471-7.
105. Leckman JF, Grice DE, Barr LC, de Vries AL, Martin C, Cohen DJ, et al. Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety 1994;1:208-15.
106. Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF, et al. Obsessive-compulsive disorder with and without a chronic tic disorder: a comparison of symptoms in 70 patients. Br J Psychiatry 1994;164:469-73.
107. Miguel EC, Coffey BJ, Baer L, Savage CR, Rauch SL, Jenike MA. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry 1995;56:246-55.
108. Miguel EC, Baer L, Coffey BJ, Rauch SL, Savage CR, O'Sullivan RL, et al. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry 1997;170:140-5.
109. George MS, Trimble MR, Ring HA, Sallee FR, Robertson MM. Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry 1993;150:93-7.
110. Pitman RK, Green RC, Jenike MA, Mesulam MM. Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry 1987;144:1166-71.
111. Cath DC, Spinhoven P, van Woerkom TC, van de Wetering BJ, Hoogduin CA, Landman AD, et al. Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without ties: which symptoms discriminate? J Nerv Ment Dis 2001;189:219-28.
112. Muller N, Putz A, Kathmann N, Lehle R, Gunther W, Straube A. Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder, and Parkinson's disease. Psychiatry Res 1997;70:105-14.
113. Baer L, Jenike MA, Ricciardi JN 2nd, Holland AD, Seymour RJ, Minichiello WE, et al. Standardized assessment of personality disorders in obsessive-compulsive disorder. Arch Gen Psychiatry 1990;47:826-30.
114. Black DW, Noyes R Jr, Pfohl B, Goldstein RB, Blum N. Personality disorder in obsessive-compulsive volunteers, well comparison subjects, and their first-degree relatives. Am J Psychiatry 1993;150:1226-32.
115. Thomsen PH, Mikkelsen HU. Development of personality disorders in children and adolescents with obsessive-compulsive disorder. A 6- to 22-year follow-up study. Acta Psychiatr Scand 1993;87:456-62.
116. Bejerot S, Schlette P, Ekselius L, Adolfsson R, von Knorring L. Personality disorders and relationship to personality dimensions measured by the Temperament and Character Inventory in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 1998;98:243-9.
117. Matsunaga H, Kiriike N, Miyata A, Iwasaki Y, Matsui T, Nagata T, et al. Personality disorders in patients with obsessive-compulsive disorder in Japan. Acta Psychiatr Scand 1998;98:128-34.
118. Mavissakalian M, Hamann MS, Jones B. Correlates of DSM-III personality disorder in obsessive-compulsive disorder. Compr Psychiatry 1990;31:481-9.
119. Mavissakalian MR, Hamann MS, Abou HS, de Groot CM. DSM-III personality disorders in generalized anxiety, panic/ agoraphobia, and obsessive-compulsive disorders. Compr Psychiatry 1993;34:243-8.
120. Baer L, Jenike MA. Personality disorders in obsessive compulsive disorder. Psychiatr Clin North Am 1992;15:803-12.
121. Norman RM, Davies F, Malla AK, Cortese L, Nicholson IR. Relationship of obsessive-compulsive symptomatology to anxiety, depression and schizotypy in a clinical population. Br J Clin Psychol 1996;35:553-66.
122. McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, et al. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry 1990;147:652-4.
123. Sobin C, Blundell ML, Weiller F, Gavigan C, Haiman C, Karayiorgou M. Evidence of a schizotypy subtype in OCD. J Psychiatr Res 2000;34:15-24.
124. Goldstein WN. Obsessive-compulsive behavior, DSM-III, and a psychodynamic classification of psychopathology. Am J Psychother 1985;39:346-59.
125. Samuels J, Nestadt G, Bienvenu OJ, Costa PT, Jr., Riddle MA, Liang KY, et al. Personality disorders and normal personality dimensions in obsessive-compulsive disorder. Br J Psychiatry 2000;177:457-62.
126. Thomsen PH, Mikkelsen HU. Course of obsessive-compulsive disorder in children and adolescents: a prospective follow-up study of 23 Danish cases. J Am Acad Child Adolesc Psychiatry 1995;34:1432-40.
127. Perugi G, Akiskal HS, Gemignani A, Pfanner C, Presta S, Milanfranchi A, et al. Episodic course in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 1998;248:240-4.
128. Demal U, Lenz G, Mayrhofer A, Zapotoczky HG, Zitterl W. Obsessive-compulsive disorder and depression. A retrospective study on course and interaction. Psychopathology 1993; 26:145-50.
129. Alarcon RD, Libb JW, Spitler D. A predictive study of obsessive-compulsive disorder response to clomipramine. J Clin Psychopharmacol 1993;13:210-3.
130. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry 1995;56:368-73.
131. Leonard HL, Lenane MC, Swedo SE, Rettew DC, Gershon ES, Rapoport JL. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry 1992;149:1244-51.
132. Leckman JF. Tourette's Syndrome. In: Hollander E, ed. Obsessive-compulsive related disorders. Washington, DC: American Psychiatric Press, 1993:113-38.
133. Coffey BJ, Miguel EC, Biederman J, Baer L, Rauch SL,O'Sullivan RL, et al. Tourette's disorder with and withoutobsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis 1998;186:201-6.
134. Como PG. Obsessive-compulsive disorder in Tourette's syndrome. Adv Neurol 1995;65:281-91.
135. Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ. "Just right" perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry 1994;151:675-80.
136. Moriarty J, Eapen V, Costa DC, Gacinovic S, Trimble M, Ell PJ, et al. HMPAO SPET does not distinguish obsessive-compulsive and tic syndromes in families multiply affected with Gilles de la Tourette's syndrome. Psychol Med 1997;27:737-40.
137. Pauls DL, Towbin KE, Leckman JF, Zahner GE, Cohen DJ. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry 1986;43:1180-2.
138. Grimshaw L. Obsessional disorder and neurological illness. J Neurol Neurosurg Psychiatry 1964;27:229.
139. Hollander E, DeCaria CM, Sauoud J, Klein DF, Liebowitz MR. Neurological soft signs in obsessive-compulsive disorder. Arch Gen Psychiatry 1991;48:278-9.
140. Hymas N, Lees A, Bolton D, Epps K, Head D. The neurology of obsessional slowness. Brain 1991;114:2203-33.
141. Stein DJ, Hollander E, Chan S, DeCaria CM, Hilal S, Liebowitz MR, et al. Computed tomography and neurological soft signs in obsessive-compulsive disorder. Psychiatry Res 1993;50:143-50.
142. Thienemann M, Koran LM. Do soft signs predict treatment outcome in obsessive-compulsive disorder? J Neuropsychiatry Clin Neurosci 1995;7:218-22.
143. Thomsen PH, Jensen J. Latent class analysis of organic aspects of obsessive-compulsive disorder in children and adolescents. Acta Psychiatr Scand 1991;84:391-5.
144. Yaryura-Tobias JA, Anderson MC, Neziroglu FA. Organicity in obsessive-compulsive disorder. Behav Modif 2000;24:553-65.
145. Deltito JA. Valproate pretreatment for the difficult-to-treat patient with OCD. J Clin Psychiatry 1994;55:500.
146. Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, et al. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Res 1993;50: 25-32.
147. Baxter LR Jr. Positron emission tomography studies of cerebral glucose metabolism in obsessive compulsive disorder. J Clin Psychiatry 1994;55(suppl):54-9.
148. Robinson D, Wu H, Munne RA, Ashtari M, Alvir JM, Lerner G, et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry 1995;52:393-8.
149. Cummings JL, Benson DF. Psychological dysfunction accompanying subcortical dementias. Annu Rev Med 1988;39:53-61.
150. Savage CR. Neuropsychology of subcortical dementias. Psychiatr Clin North Am 1997;20:911-31.
151. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998;26-37.
152. Rauch SL, Baxter LR. Neuroimaging in obsessive-compulsive disorder and related disorders. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-compulsive disorders: practical management. St. Louis, MO: Mosby, 1998: 289-317.
153. Greenberg BD, Ziemann U, Cora-Locatelli G, Harmon A, Murphy DL, Keel JC, et al. Altered cortical excitability in obsessive-compulsive disorder. Neurology 2000;54:14-27.
154. Hugo F, Van Heerden B, Zungu-Dirwayi N, Stein DJ. Functional brain imaging in obsessive-compulsive disorder secondary to neurological lesions. Depress Anxiety 1999;10:129-36.
155. Berthier ML, Kulisevsky J, Gironell A, Heras JA. Obsessive-compulsive disorder associated with brain lesions: clinical phenomenology, cognitive function, and anatomic correlates. Neurology 1996;47:353-61.
156. Rauch SL, Savage CR. Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. Psychiatr Clin North Am 1997;20:741-68.
157. Swedo SE, Leonard HL. Childhood movement disorders and obsessive compulsive disorder. J Clin Psychiatry 1994;55(suppl):32-7.
158. Swedo SE, Leonard HL, Kiessling LS. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 1994;93:323-6.
159. Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1995;34:307-11.
160. Leonard HL, Swedo SE. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). Int J Neuropsychopharmacol 2001;4:191-8.
161. Swedo SE, Leonard H, Mittleman BB, Allen AJ, Rapoport JL, Dow SP, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997;154:110-2.
162. Murphy TK, Goodman WK, Fudge MW, Williams RC, Ayoub EM, Dalal M, et al. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry 1997;154:402-7.
163. Pitman RK. Posttraumatic obsessive-compulsive disorder: a case study. Compr Psychiatry 1993;34:102-7.
164. de Silva P, Marks M. The role of traumatic experiences in the genesis of obsessive-compulsive disorder. Behav Res Ther 1999;37:941-51.
165. Trumbull DW. Obsessive-compulsive symptomatology: a goal-directed response to anticipated traumatization? Psychiatry 2001;64:309-18.
166. Albert U, Maina G, Ravizza L, Bogetto F. An exploratory study on obsessive-compulsive disorder with and without a familial component: are there any phenomenological differences? Psychopathology 2002;35:8-16.
167. Lewis A. Problems of obsessional illness. Proceedings of the Royal Society of Medicine 1936;29:325-36.
168. Brown FW. Heredity in the psychoneuroses. Proceedings of the Royal Society of Medicine 1942;35:785-90.
169. Kringlen E. Obsessional neurotics: a long-term follow-up. Br J Psychiatry 1965;111:709-22.
170. Lo WH. A follow-up study of obsessional neurotics in Hong Kong Chinese. Br J Psychiatry 1967;113:823-32.
171. Rosenberg CM. Familial aspects of obsessional neurosis. Br J Psychiatry 1967;113:405-13.
172. Insel TR, Hoover CF, Murphy DL. Parents of patients with obsessive-compulsive disorder. Psychol Med 1983;13:807-11.
173. McKeon P, Murray R. Familial aspects of obsessive-compulsive neurosis. Br J Psychiatry 1987;151:528-34.
174. Riddle MA, Scahill L, King R, Hardin MT, Towbin KE, Ort SI, et al. Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry 1990;29:766-72.
175. Bellodi L, Sciuto G, Diaferia G, Ronchi P, Smeraldi E. Psychiatric disorders in the families of patients with obsessive-compulsive disorder. Psychiatry Res 1992;42:111-20.
176. Black DW, Noyes R, Jr., Goldstein RB, Blum N. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:36-68.
177. Nicolini H, Weissbecker K, Mejia JM, Sanchez dC. Family study of obsessive-compulsive disorder in a Mexican population. Arch Med Res 1993;24:193-8.
178. Nestadt G, Samuels J, Riddle M, Bienvenu OJ III, Liang KY, LaBuda M, et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000;57:358-63.
179. Bellodi L, Cavallini MC, Bertelli S, Chiapparino D, Riboldi C, Smeraldi E. Morbidity risk for obsessive-compulsive spectrum disorders in first-degree relatives of patients with eating disorders. Am J Psychiatry 2001;158:563-9.
180. Leonard HL, Swedo SE, Rapoport JL, Koby EV., Lenane MC, Cheslow DL, et al. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Arch Gen Psychiatry 1989;46:1088-92.
181. Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry 1990;47:926-32.
182. Goodman WK, McDougle CJ, Price LH. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder. Int Clin Psychopharmacol 1992;7(suppl 1):35-8.
183. Mohr N, Vythilingum B, Emsley RA, Stein DJ. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder. Int Clin Psychopharmacol 2002;17:37-40.
184. Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999;156:1409-16.
185. Black DW, Monahan P, Gable J, Blum N, Clancy G, Baker P. Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry 1998;59:420-5.
186. Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry 2001;62:535-40.
187. Leonard HL, Swedo SE, Lenane MC, Rettew DC, Hamburger SD, Bartko JJ, et al. A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry 1993;50:429-39.
188. Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Arch Gen Psychiatry 1980;37:1281-5.
189. DeVeaugh-Geiss J, Katz R, Landau P. Clomipramine in the treatment of patients with obsessive-compulsive disorder: the Clomipramine Collaborative Study Group. Arch Gen Psychiatry 1991;48:730-8.
190. Buchanan AW, Meng KS, Marks IM. What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder? Anxiety 1996;2:22-7.
191. Basoglu M, Lax T, Kasvikis Y, Marks I. Predictors of improvement in obsessive-compulsive disorder. J Anxiety Disord 1988;2:299-317.
192. Foa EB, Goldstein A. Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behav Ther 1978;9:821-9.
193. Marks IM, Lelliott P, Basoglu M, Noshirvani H, Monteiro W, Cohen D, et al. Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. Br J Psychiatry 1988;152:522-34.
194. Clark DA, Sugrim I, Bolton D. Primary obsessional slowness: a nursing treatment programme with a 13-year-old male adolescent. Behav Res Ther 1982;20:289-92.
195. Christensen H, Hadzi-Pavlovic D, Andrews G, Mattick R. Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol 1987;55:701-11.
196. Erzegovesi S, Cavallini MC, Cavedini P, Diaferia G, Locatelli M, Bellodi L. Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol 2001;21:488-92.
197. Mundo E, Bareggi SR, Pirola R, Bellodi L. Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable? Biol Psychiatry 1999;45:290-4.
198. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994;51:302-8.
199. Ackerman DL, Greenland S, Bystritsky A. Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 1998;18:185-92.
200. den Boer JA. Psychopharmacology of comorbid obsessive-compulsive disorder and depression. J Clin Psychiatry 1997;58(suppl 8):17-9.
201. Zitterl W, Lenz G, Mairhofer A, Zapotoczky HG. Obsessive-compulsive disorder: course and interaction with depression. A review of the literature. Psychopathology 1990;23:73-80.
202. Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R. Fluvoxamine treatment of obsessive-compulsive disorder. Am J Psychiatry 1987;144:1543-8.
203. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry 1989;46:36-44.
204. Foa EB, Kozak MJ, Steketee GS, McCarthy PR. Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy. Br J Clin Psychol 1992;31:279-92.
205. Gershuny BS, Baer L, Jenike MA, Minichiello WE, Wilhelm S. Comorbid posttraumatic stress disorder: impact on treatment outcome for obsessive-compulsive disorder. Am J Psychiatry 2002;159:852-4.
206. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol 1993;13:354-8.
207. Bogetto F, Bellino S, Vaschetto P, Ziero S. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial. Psychiatry Res 2000;96:91-8.
208. McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000;57:794-801.
209. Dowling FG, Pato MT, Pato CN. Comorbidity of obsessive-compulsive and psychotic symptoms: a review. Harv Rev Psychiatry 1995;3:75-83.
210. Ganesan V, Kumar TC, Khanna S. Obsessive-compulsive disorder and psychosis. Can J Psychiatry 2001;46:750-4.
211. Cheung EF. Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia. Aust N Z J Psychiatry 2001;35:695-6.
212. Khullar A, Chue O, Tibbo P. Quetiapine and obsessive-compulsive symptoms (OCS): Case report and review of atypical antipsychotic-induced OCS. J Psychiatry Neurosci 2001;26:55-9.
213. de Haan L, Beuk N, Hoogenboom B, Dingemans P, Linszen D. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry 2002;63:104-7.
214. Minichiello WE, Baer L, Jenike MA. Schizotypal personality disorder: a poor prognostic indicator for behavior therapy in the treatment of obsessive-compulsive disorder. J Anxiety Disord 1987;1:273-6.
215. Pfohl B, Black DW, Noyes R, Coryell WH, Barreira PJ. Axis I and Axis II comorbidity findings: implications for validity. In Oldham JM, ed. Personality disorders: new perspectives on diagnostic validity. Washington, DC: American Psychiatric Press, 1991.
216. Baer L, Jenike MA, Black DW, Treece C, Rosenfeld R, Greist J. Effect of Axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:862-6.
217. Jenike MA, Baer L, Minichiello WE, Schwartz CE, Carey RJ Jr. Concomitant obsessive-compulsive disorder and schizotypal personality disorder. Am J Psychiatry 1986;143:530-2.
218. Hermesh H, Shahar A, Munitz H. Obsessive-compulsive disorder and borderline personality disorder. Am J Psychiatry 1987;144:120-2.
219. Steketee G. Personality traits and disorders in obsessive-compulsives. J Anxiety Disord 1990;4:351-64.
220. Mavissakalian M, Hamann MS, Jones B. DSM-III personality disorders in obsessive-compulsive disorder: changes with treatment. Compr Psychiatry 1990;31:432-7.
221. Ackerman DL, Greenland S, Bystritsky A. Side effects as predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol 1999;19:459-65.
222. Bolton D, Raven P, Madronal-Luque R, Marks IM. Neurological and neuropsychological signs in obsessive compulsive disorder: interaction with behavioural treatment. Behav Res Ther 2000;38:695-708.
223. Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, et al. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 1998;84:1-6.
224. Saxena S, Bota RG, Brody AL. Brain-behavior relationships in obsessive-compulsive disorder. Semin Clin Neuropsychiatry 2001;6:82-101.
225. Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, et al. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 1992;49:21-8.
226. Hollander E, DeCaria C, Stein D, Simeon D, Cohen L, Hwang M, et al. Behavioral response to m-CPP. Biol Psychiatry 1994;35:426-7.
227. Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, et al. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Biol Psychiatry 1995;38:138-49.
228. Hollander E, Cohen LJ, DeCaria C, Saoud JB, Stein DJ, Cooper TB, et al. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD. Biol Psychiatry 1993;34:407-13.
229. Hollander E, Prohovnik I, Stein DJ. Increased cerebral blood flow during m-CPP exacerbation of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 1995;7:485-90.
230. Stein DJ, Van Heerden B, Wessels CJ, van Kradenburg J, Warwick J, Wasserman HJ. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:1079-99.
231. Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry 1992;53(suppl):17-28.
232. Barr LC, Goodman WK, Price LH. The serotonin hypothesis of obsessive compulsive disorder. Int Clin Psychopharmacol 1993;8(suppl 2):79-82.
233. Ebstein RP, Benjamin J, Belmaker RH. Personality and polymorphisms of genes involved in aminergic neurotransmission. Eur J Pharmacol 2000;410:205-14.
234. Miguel EC, Rauch SL, Jenike MA. Obsessive-compulsive disorder. Psychiatr Clin North Am 1997;20:863-83.
235. Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987;236:410-6.
236. Greenberg D. Compulsive hoarding. Am J Psychother 1987;41:409-16.
237. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology 1994;19:723-49.
238. Singer HS, Hahn IH, Moran TH. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 1991;30:558-62.
239. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-80.
240. Zungu-Dirwayi N, Hugo F, van Heerden BB, Stein DJ. Are musical obsessions a temporal lobe phenomenon? J Neuropsychiatry Clin Neurosci 1999;11:398-400.
241. Swedo SE, Rapoport JL, Leonard HL, Schapiro MB, Rapoport SI, Grady CL. Regional cerebral glucose metabolism of women with trichotillomania. Arch Gen Psychiatry 1991;48:828-33.
242. McElroy SL, Phillips KA, Keck PE Jr. Obsessive compulsive spectrum disorder. J Clin Psychiatry 1994;55(suppl):33-51.
243. Stein DJ, Hollander E. The spectrum of obsessive-compulsive related disorders. In: Hollander E, ed. Obsessive-compulsive related disorders. Washington, DC: American Psychiatric Press, 1993:241-71.
244. Stein DJ, Hollander E. Impulsive aggression and obsessive-compulsive disorder. Psychiatr Annals 1993;23:389-95.
245. Youn T, Lyoo I, Kim J, Park H, Ha K, Lee D, et al. Relationship between personality trait and regional cerebral glucose metabolism assessed with positron emission tomography. Biol Psychol 2002;60:109.